Nebulized enriched heparin improves respiratory parameters in patients with COVID-19
Heparin, a sulphated polysaccharide, shows potential antiviral action against SARS-CoV-2, binding to the virus's spike protein to inhibit infection. A study evaluated inhaled enriched heparin's safety and efficacy in COVID-19 patients, revealing a significant decrease in viral load without cytotoxicity, suggesting dual antiviral and antithrombotic effects.
Related Clinical Trials
Reference News
Nebulized enriched heparin improves respiratory parameters in patients with COVID-19
Heparin, a sulphated polysaccharide, shows potential antiviral action against SARS-CoV-2, binding to the virus's spike protein to inhibit infection. A study evaluated inhaled enriched heparin's safety and efficacy in COVID-19 patients, revealing a significant decrease in viral load without cytotoxicity, suggesting dual antiviral and antithrombotic effects.